Emerging vs Developed Markets
Emerging vs Developed Markets
Emerging markets are growing faster than developed markets but are more volatile and risky. A market-weight allocation holds roughly 35% of international stocks in emerging markets automatically. Explicit EM overweights require conviction; most investors do better with the default weighting.
Key takeaways
- Emerging markets (China, India, Brazil, Mexico, Vietnam) represent 35% of global market cap but 45–50% of GDP growth
- They are faster-growing but more volatile, with higher political and currency risk
- Market-weight allocation (35% of international stocks in EM) is optimal for most investors without a strong forecast
- Explicit EM overweights (50%+) are bets on future outperformance; they have worked sometimes but underperformed recently
- Developing markets have lower valuations (P/E ratios) than developed markets, suggesting potential value, but this persists across decades without consistent outperformance
Defining Emerging vs Developed Markets
Developed markets include the U.S., Europe (UK, France, Germany, etc.), Japan, Australia, Canada, and South Korea. They have mature economies, strong rule of law, transparent markets, and lower growth (2–3% GDP growth).
Emerging markets include China, India, Brazil, Mexico, Vietnam, Taiwan, and dozens of others. They have rapidly growing economies (5–10% GDP growth), developing institutions, and higher volatility. They represent about 35% of global market capitalization but over 50% of global GDP growth.
The Economic Case for Emerging Markets
By GDP, emerging markets are the world's growth engine. China and India alone represent 35% of global GDP growth. Brazil, Mexico, and Vietnam are adding substantial growth.
By this logic, emerging markets should be the most attractive investment opportunity. You are betting on the world's fastest-growing economies.
However, fast GDP growth does not automatically translate to stock returns. Why? Because valuations adjust. If everyone knows China is growing fast, that knowledge is priced into Chinese stocks. Buying them at market prices offers no advantage over buying developed markets that grow slowly but trade cheaply.
In fact, the opposite often happens: emerging markets trade at premium valuations because everyone is excited about them, while developed markets trade at discounts because growth is slow. A cheap developed market can outperform a cheap emerging market.
Market Capitalization vs GDP
This distinction matters:
- Market cap: What the stock market is worth today. Emerging markets are ~35% of global cap.
- GDP: Total economic output. Emerging markets are ~50% of global GDP.
The gap reflects valuation differences: developed market stocks are more expensive (higher P/E ratios), while emerging market stocks are cheaper. A dollar of GDP in the U.S. trades for $2.50 in market value; a dollar of GDP in China trades for $1.50.
This means emerging markets are cheaper on a GDP basis, which is attractive. But the question is: will EM valuations converge upward to DM levels, or will DM valuations compress? History is mixed.
Historical Performance: EM vs DM
| Period | Emerging Markets | Developed Markets | Winner |
|---|---|---|---|
| 1990–2000 | +19% CAGR | +18% CAGR | EM (slight) |
| 2000–2010 | +14% CAGR | +6% CAGR | EM (huge) |
| 2010–2020 | +5% CAGR | +13% CAGR | DM |
| 2020–2024 | +10% CAGR | +18% CAGR | DM |
Emerging markets dominated the 2000s, when China and India boomed. But developed markets have dominated the 2010s–2020s, driven by U.S. tech (Apple, Microsoft, Google, Nvidia).
This alternation is typical. Neither EM nor DM consistently outperforms. A forecast that "EM will outperform because they're growing faster" is reasonable but has been wrong for 15 years.
Market-Weight Allocation (Default)
A simple approach: hold emerging and developed markets in their market-cap weights. A global developed/emerging index fund automatically does this.
Example splits:
- VXUS (Vanguard Total International): 60% developed, 40% emerging markets
- IEFA + IEMG (separate funds): You choose the split
A 50/50 U.S./International portfolio with market-weight international allocation looks like:
| Asset | % of Total | % of Stocks |
|---|---|---|
| U.S. stocks | 30% | 50% |
| Developed international | 15% | 25% |
| Emerging markets | 15% | 25% |
| Bonds | 40% | — |
This reflects global market weights and requires no forecast about which region will outperform.
The EM Value Case
Emerging markets trade at cheaper valuations than developed markets:
| Metric | Developed | Emerging |
|---|---|---|
| P/E ratio (price/earnings) | 18–20x | 12–14x |
| P/B ratio (price/book) | 3–4x | 1.5–2.5x |
| Dividend yield | 2–3% | 3–4% |
By these metrics, emerging markets are 30–40% cheaper. This attracts value investors to overweight them.
However, this valuation gap has persisted for 20+ years without consistently producing EM outperformance. Why?
-
Risk premium: Investors charge a lower price for EM stocks because they are riskier (political instability, currency risk, less transparency). The lower price reflects appropriate compensation for risk.
-
Currency headwinds: Many EM currencies have weakened against the dollar over decades. This creates a return drag for U.S. dollar investors.
-
Regulatory and geopolitical risks: China's clampdown on tech companies in 2020–2022 wiped out gains from that decade.
Explicit EM Tilts
Some investors deliberately overweight emerging markets, holding 50%+ of international stocks in EM instead of the market-weight 35–40%. This is a forecast that EM will outperform.
Historically, this has worked episodically: 2000–2010 was a huge win for EM tilts. But 2010–2024 has been a loss: EM underperformance has been persistent.
A 2023 study found that investors who overweighted EM in the 2000s (when it was working) were psychologically incentivized to maintain the tilt even as it stopped working in the 2010s. This is a classic behavioral mistake: chasing past performance.
Recommendation for most investors: Stick with market-weight allocation (35–40% EM within international) unless you have strong conviction and a multi-decade time horizon. The burden of proof is on you to outthink global markets, which is high.
China-Specific Considerations
China is roughly 20% of emerging markets and 7% of global market cap. A market-weight allocation to EM automatically includes significant China exposure.
Some investors worry about China's political stability and governance risk. Others see China as offering growth at attractive valuations. Both views have merit.
A few options:
- Accept market weight: Hold China in your EM allocation, reflecting its market cap.
- Overweight China: If you believe China's growth will drive returns, overweight it.
- Underweight China: If you're concerned about political risk, hold less than market weight.
For most investors with long time horizons, accepting market weight is simplest. China is important but not the entire story; you're diversified.
Portfolio Construction with EM
If you want a granular portfolio:
| Asset | Target % | Fund |
|---|---|---|
| U.S. stocks | 30% | VTI |
| Developed international | 12% | IEFA (Europe, Japan, etc.) |
| Emerging markets | 8% | VWO or IEMG |
| Bonds | 50% | BND + TIP |
This is 50/50 U.S./International with market-weight EM split.
Or, if you want to overweight EM:
| Asset | Target % | Fund |
|---|---|---|
| U.S. stocks | 30% | VTI |
| Developed international | 10% | IEFA |
| Emerging markets | 10% | VWO or IEMG |
| Bonds | 50% | BND + TIP |
This tilts toward EM (50% of international vs. market-weight 40%).
Rebalancing EM Exposure
If you hold separate developed and emerging funds, rebalance them annually along with your stocks/bonds. If EM outperforms and grows to 11% when you target 8%, trim it and buy developed.
This forced "buy low, sell high" discipline is valuable. It also discourages you from chasing hot sectors; you systematically reduce winners and buy losers.
Volatility of EM
Emerging market stocks are 20–30% more volatile than developed market stocks. A 60/40 portfolio with 25% EM weighting has slightly higher volatility (10.5–11% standard deviation) than one with 15% EM weighting (10–10.5%).
This small difference is unlikely to matter for most investors' behavior, but it's worth noting.
Process
Next
You have now covered the major allocation decisions: stocks/bonds/cash, U.S./international, and developed/emerging markets. The final tactical question is: within your U.S. stock allocation, should you explicitly tilt toward small-cap and mid-cap stocks, or hold total-market (which is market-weighted by cap)? The next article explores this final frontier of allocation.